Akari Therapeutics PLC (NASDAQ:AKTX)

9.60
Delayed Data
As of Aug 26
 -0.4899 / -4.86%
Today’s Change
7.63
Today|||52-Week Range
36.94
-33.79%
Year-to-Date
No recent news for Akari Therapeutics PLC.

Today’s Trading

Previous close10.09
Today’s open9.62
Day’s range9.60 - 9.62
Volume460
Average volume (3 months)6,241
Market cap$113.1M
Dividend yield--
Data as of 10:53am ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+72.16%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.32

Competitors

 Today’s
change
Today’s
% change
ASTAsterias Biotherapeu...+0.03+1.10%
PTIEPain Therapeutics In...+0.07+2.97%
VBIVVBI Vaccines Inc+0.02+0.55%
PSDVpSivida Corp-0.03-0.76%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateAugust 29, 2016
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$0.00
Annual profit (last year)-$45.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO, Director, Head-Investor &
Media Relations
Gur A. Roshwalb
Chief Operating Officer &
Director
Clive Richardson
Corporate headquarters
London, Greater London

Forecasts

Partner Offers

NextAdvisor